Abstract
Objective In-hospital mortality rates in patients successfully resuscitated following out-of-hospital cardiac arrest (OHCA) remains high. Little has been published regarding the timing and putative causes of in-hospital death during the post-cardiac arrest resuscitation phase of care. In this study, we aimed to develop a novel two-stage categorization system and investigate the timing and factors associated with post-CA in-hospital death.
Design Single-centered retrospective observational human study.
Setting Adult Emergency Department and ICU in a university affiliated hospital.
Patients Two hundred and forty-one adult, non-traumatic OHCA patients.
Interventions None.
Measurements and Main Results Through an expert consensus process, a two-stage classification system of hospital deaths was developed. Data abstraction was performed by two researchers and inter-reliability was 0.858. We categorized deaths as being due to withdrawal of life sustaining treatment (WOLST) 159 (66.0%), recurrent in-hospital cardiac arrest 51 (21.1%), and declared dead by neurological criteria 31 (12.9%). Half of WOLST decisions occurred primarily in the setting of isolated neurological injury. Early in-hospital death (≤ 3 days) was associated with recurrent in-hospital cardiac arrest and WOLST with refractory shock or multi-organ injury. Late in-hospital death (> 3 days) was associated with WOLST due to neurological injury. Age, initial lactate level, duration of CPR exceeding 30 minutes, and vasopressor dependence post ROSC was found to be the dependent predictors for Early death during hospital stay.
Conclusions Our novel two-stage categorization scheme for post-CA deaths demonstrated high inter-rater reliability. The majority of in-hospital post-CA deaths were due to neurological injury associated with WOLST. Early deaths were largely attributed to recurrent in-hospital cardiac arrest, and WOLST due to refractory shock or multi-organ injury while Late deaths occurred in the context of neurological injury demonstrating two phases of injury in the post-CA syndrome.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for Dr. Shu Li MD was provided by Clinical Leadership Development Fellowship of Peking University Third Hospital (2018, China). Funding for Dr. Willard W. Sharp was provided by NIH R01HL133675-03. The remaining authors have disclosed that there is no financial, consultant, institutional, and other relationships that might lead to bias or a conflict of interest.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Name of institution where the work was performed: The University of Chicago Medicine
The address for reprints: The University of Chicago, MC 5068, 5841 S Maryland Ave, Chicago, IL 60637, United States
A statement regarding whether reprints will be ordered: no.
Conflicts of Interest and Source of Funding Funding for Dr. Shu Li MD was provided by Clinical Leadership Development Fellowship of Peking University Third Hospital (2018, China). Funding for Dr. Willard W. Sharp was provided by NIH R01HL133675-03. The remaining authors have disclosed that there is no financial, consultant, institutional, and other relationships that might lead to bias or a conflict of interest.
Data Availability
To facilitate this study and to monitor quality of care, a REDCAP HIPPA secure registry was maintained with EMR as source data.